Alessandro Villa, DDS, PhD, MPH
Alessandro Villa, D.D.S., Ph.D., M.P.H., is chief of oral medicine, oral oncology and dentistry at Miami Cancer Institute where he also serves as the Program Director of the Oral Oncology Fellowship. In addition, he is a Professor at the Herbert Wertheim College of Medicine, FIU. Dr. Villa specializes in treating oral mucosal and salivary gland diseases, oral precancers and oral complications from cancer treatment. Prior to joining Miami Cancer Institute in 2022, Dr. Villa was an attending physician at the University of California San Francisco, Medical Center and an associate clinical professor of oral medicine and otolaryngology at University of California San Francisco (UCSF). He also directed the oral medicine residency programs at UCSF and Harvard. Dr. Villa’s research focuses on oral dysplasia, oral complications from cancer therapy and prevention of HPV-associated oropharyngeal cancers. He is involved in several investigator initiated and sponsored clinical trials and has published more than 130 peer-reviewed manuscripts.
Financial relationships
-
Attribution:SelfType of financial relationship:OtherIneligible company:MerckTopic:Consultant on HPVDate added:11/20/2023Date updated:01/26/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Lipella PharmaceuticalsTopic:Consultant on lichen plansDate added:11/20/2023Date updated:01/26/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:K PHARMACEUTICALSTopic:Consultant on dry mouthDate added:11/20/2023Date updated:01/26/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:Afyx TherapeuticsTopic:LeukoplakiaDate added:01/26/2024Date updated:01/26/2024
-
Type of financial relationship:Grant Or ContractIneligible company:MurevaTopic:Oral mucositis (research support)Date added:01/26/2024Date updated:01/26/2024
-
Type of financial relationship:Grant Or ContractIneligible company:MerckTopic:Research supportDate added:01/26/2024Date updated:01/26/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:UptodateTopic:RoyaltiesDate added:01/26/2024Date updated:01/26/2024